pyruvaldehyde has been researched along with apigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Vázquez, JA | 1 |
| Cheng, KW; Gong, J; Li, ETS; Wang, M; Zhou, Q | 1 |
| Gong, D; Ni, M; Pan, J; Song, X; Zhang, G | 1 |
3 other study(ies) available for pyruvaldehyde and apigenin
| Article | Year |
|---|---|
Modeling of chemical inhibition from amyloid protein aggregation kinetics.
Topics: Amyloid beta-Peptides; Apigenin; Biflavonoids; Catechin; Flavones; Insulin; Insulin Antagonists; Kinetics; Models, Biological; Peptide Fragments; Phosphatidylcholines; Pyruvaldehyde | 2014 |
Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells.
Topics: Animals; Apigenin; Cell Survival; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Oxidative Stress; Pyruvaldehyde; Swine | 2019 |
Vitexin Inhibits Protein Glycation through Structural Protection, Methylglyoxal Trapping, and Alteration of Glycation Site.
Topics: Apigenin; Glycation End Products, Advanced; Glycosylation; Pyruvaldehyde; Serum Albumin, Bovine; Tandem Mass Spectrometry | 2021 |